Two GlaxoSmithKline Drugs Approved by FDA

Two new GlaxoSmithKline drugs to treat advanced skin cancer, Tafinlar (dabrafenib) and Mekinist (trametinib), were granted Food and Drug Administration approval on Tuesday. GSK's national headquarters are located in Durham in Research Triangle Park.